n(6)-carboxymethyllysine has been researched along with Diathesis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cotch, MF; Eiríksdottir, G; Ferrucci, L; Gudnason, V; Harris, TB; Jonasson, F; Klein, R; Schaumberg, DA; Semba, RD; Sun, K | 1 |
| Cleary, P; Dahms, W; Genuth, S; Malone, J; Monnier, VM; Sell, DR; Sivitz, W; Sun, W | 1 |
2 other study(ies) available for n(6)-carboxymethyllysine and Diathesis
| Article | Year |
|---|---|
Serum carboxymethyllysine, an advanced glycation end product, and age-related macular degeneration: the Age, Gene/Environment Susceptibility-Reykjavik Study.
Topics: Age Factors; Aged; Aged, 80 and over; Cross-Sectional Studies; Disease Susceptibility; Enzyme-Linked Immunosorbent Assay; Female; Gene-Environment Interaction; Glycation End Products, Advanced; Humans; Iceland; Logistic Models; Lysine; Macular Degeneration; Male; Prevalence; Risk Factors; Visual Acuity | 2014 |
Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications p
Topics: Adult; Biopsy; Collagen; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Disease Progression; Disease Susceptibility; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Prognosis; Skin; Time Factors | 2005 |